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Abstract 
 
Inducible protein degradation techniques have considerable advantages over classical genetic 
approaches, which generate loss-of-function phenotypes at the gene or mRNA level. The 
plant-derived auxin-inducible degradation system (AID) is a promising technique which 
enables the degradation of target proteins tagged with the AID motif in non-plant cells. Here, 
we present a detailed characterization of this method employed during the adult oogenesis of 
Drosophila. Furthermore, with the help of CRISPR/Cas9-based genome editing, we improve 
the utility of the AID system in the conditional elimination of endogenously expressed 
proteins. We demonstrate that the AID system induces efficient and reversible protein 
depletion of maternally provided proteins both in the ovary and the early embryo. Moreover, 
the AID system provides a fine spatiotemporal control of protein degradation and allows for 
the generation of different levels of protein knockdown in a well-regulated manner. These 
features of the AID system enable the unravelling of the discrete phenotypes of genes with 
highly complex functions. We utilized this system to generate a conditional loss-of-function 
allele which allows for the specific degradation of the Vasa protein without affecting its 
alternative splice variant (solo) and the vasa intronic gene (vig). With the help of this special 
allele, we demonstrate that dramatic decrease of Vasa protein in the vitellarium does not 
influence the completion of oogenesis as well as the establishment of proper anteroposterior 
and dorsoventral polarity in the developing oocyte. Our study suggests that both the 
localization and the translation of gurken mRNA in the vitellarium is independent from Vasa. 
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Introduction 
 
Drosophila provides a variety of experimental tools for the elimination of target proteins in 
order to analyze their functions in the living organism. The most frequently used techniques 
manipulate protein expression at the gene or mRNA level. However, the loss-of-function 
phenotypes generated at the gene level are irreversible. RNA interference techniques enable 
conditional regulation, but they act on the protein level in an indirect manner, and the ensuing 
effects depend on the turnover rate of the actual protein. This can be a particular problem in 
the case of the highly stable maternally provided proteins. In Drosophila, a significant level of 
maternally derived mRNAs and proteins are loaded into the egg, and many of them may 
persist throughout the whole embryogenesis. In addition, several maternal effect genes are 
expressed in all developmental stages and have crucial and pleiotropic functions in many key 
events, including oogenesis [1–5]. This further complicates their analysis, because 
homozygous null mutations of maternal effect genes often cause lethality or female sterility, 
making the examination of both their later functions and their maternal effects in the embryo 
impossible. Weak or temperature-sensitive alleles can overcome these limitations, however, 
they are not always available for a given gene. In addition, mutant alleles often affect more 
splice variants, which makes the investigation of specific phenotypes more confounding. 
Recently, a variety of methods have been developed that are able to induce direct and specific 
protein degradation. Some of them, such as the TEV protease-mediated cleavage or the GFP-
nanobody-directed degradation [6,7], have been adapted to Drosophila. These methods 
provide conditional protein depletion that can be regulated by the tissue-specific expression of 
the TEV protease or the GFP-nanobody. Other methods such as photo-inactivation by FlAsH-
FALI or the temperature-sensitive intein enable a more defined spatiotemporal protein 
depletion [8,9]. However, both the reactive oxygen species generated by FlAsH-FALI and the 
elevated temperature can result in unwanted physiological changes and off-target effects. 
The plant-derived auxin-inducible degradation (AID) system is a promising technique to 
induce rapid and reversible protein depletion [10]. This method is based on the ability of the 
plant F-box protein TIR1 to incorporate into the highly conserved SKP1/CUL1/F-box (SCF) 
ubiquitin ligase complex in non-plant cells. Therefore, the heterologously expressed plant 
TIR1 protein is able to induce the polyubiquitination and proteasomal degradation of target 
proteins tagged with the auxin-inducible degron (AID) motif. The TIR1 protein binds to the 
AID motif exclusively in the presence of the auxin hormone. Auxin is a cell-permeable small 
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molecule and can easily penetrate into cells, which provides an excellent possibility for 
temporal control of protein degradation. The AID system was first applied in yeast and in 
cultured vertebrate cell lines [10–12]. Subsequently, Caenorhabditis elegans was used to 
show that this technique can be adapted to intact multicellular organisms as well [13]. A most 
recent study on Drosophila melanogaster demonstrated that the AID system is able to induce 
protein degradation in somatic cells during the larval stages without significant side effects 
[14]. 
Here, we present a detailed characterization of the AID system employed during the adult 
oogenesis of Drosophila. We applied this method to deplete Nanos and Vasa, two well-known 
and highly pleiotropic maternal effect proteins. We show that auxin administration or TIR1 
overexpression in the germline does not influence the viability and fertility of adult flies and 
has no harmful maternal effects. The AID system enables rapid and reversible protein 
degradation in the ovary, and the maternally loaded TIR1 and auxin can be functional in the 
early embryo as well. Furthermore, we demonstrate that the combination of the AID system 
with the CRISPR/Cas9-based genome editing techniques enables the complete elimination of 
endogenously expressed proteins.  
  
5 
 
Results 
 
The AID system is able to induce reversible protein degradation in the early embryo of 
Drosophila melanogaster 
To examine whether the plant-derived AID system can be functional during early 
embryogenesis, we established a fly line expressing an AID-tagged dominant negative form 
of the Nanos protein (AID:nos-bcd3’UTR). In this fly line, the localization signal of nanos 
mRNA was replaced by a localization and translational signal derived from the bicoid 3’UTR. 
These flies lay eggs in which the transgenic Nanos protein is mislocalized to the anterior pole, 
resulting in embryos with a bicaudal phenotype (Figure 1B) [15]. To introduce the AID 
system into this fly line, the AID motif was fused N-terminally to the transgenic Nanos. We 
used the minimal size AID motif, as it has been shown that this region itself induces more 
efficient protein degradation than the full-length degron [12]. The 9xMyc-tagged TIR1 
protein was expressed in the female germline under the control of UASp promoter and 
nosGal4VP16 driver. Auxin administration was achieved by feeding the flies with a paste 
prepared by dissolving inactive yeast extract in 1M auxin solution. Neither TIR1 
overexpression nor auxin treatment caused lethal effects in the adult flies. One day old, 
completely developed embryos of the AID:nos-bcd3’UTR; nosGal4VP16>UASpTIR1 
transgenic females were analyzed by cuticle preparation. Upon auxin administration, the 
dominant-negative bicaudal phenotype was suppressed, indicating that the AID system was 
able to degrade the AID-tagged mislocalized Nanos protein (Figure 1C). Suppression of the 
bicaudal phenotype appeared already at the first day of auxin treatment, and its penetrance 
increased constitutively with time, reaching the maximum on the third day. (Figure 1D). One 
day after auxin removal, the suppression decreased, and after two days no suppressed bicaudal 
phenotype was detected, demonstrating that the AID system acts in a reversible manner. 
Auxin treatment did not influence the proportion of undeveloped embryos indicating that 
auxin has no harmful maternal effects (Figure 1D).  
 
Endogenous Vasa protein can be conditionally depleted by the genomic insertion of the 
AID motif sequence  
In order to investigate the effectiveness of the AID system in degrading endogenously 
expressed proteins, we applied CRISPR/Cas9-based homologous recombination for the 
insertion of the AID motif into the genome. The vasa gene was selected for this procedure as 
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its functions and expression pattern are well known [16]. The Vasa protein is expressed in the 
germline throughout all stages of development. It is required for the completion of oogenesis, 
and the maternally loaded Vasa protein has an essential role in embryonic patterning and 
germ cell specification. Therefore, its loss-of-function phenotypes, such as oogenesis defects 
during adulthood or lack of abdominal segments and pole cells in the early embryo, can be 
easily detected.  
We introduced the minimal size AID motif sequence right before the stop codon of the vasa 
gene (Figure 2). In addition to the AID motif, an EGFP tag was also inserted to enable the 
direct visualization of the Vasa protein. The AID:EGFP tagged vasa gene was fully functional 
since in homozygous condition it resulted in a wild-type, viable and fertile phenotype. 
Expression and subcellular localization of the tagged Vasa protein in the adult ovary and in 
the early embryo was identical with that of the wild-type (Figure 3).  
To induce Vasa degradation, we expressed the TIR1 protein in the germline of flies 
homozygous for vasa:AID:EGFP using various maternal Gal4 sources (mat-tub-Gal4, NGT-
Gal4, nosGal4VP16). Flies were fed with 1M auxin for three days, and their ovaries were 
dissected to analyze Vasa and TIR1 protein expression by confocal microscopy. The level of 
the Vasa protein drastically decreased in the ovaries in all of the investigated fly lines. The 
Vasa protein was specifically absent only where the TIR1 protein was expressed, indicating 
that the pattern of degradation correlates well with TIR1 localization (Figure 4). Accordingly, 
in the ovaries of vasa:AID:EGFP; mat-tub-Gal4>UASpTIR1 females, we observed Vasa 
depletion starting from stage 2 egg chambers. Consistently, the TIR1 protein was expressed 
throughout oogenesis, except in the germarium (Figure 4A). In the vasa:AID:EGFP; NGT-
Gal4>UASpTIR1 females, the Vasa protein was absent in the later stages of oogenesis starting 
from stage 9, and we found partial Vasa degradation in the germarium as well. The TIR1 
protein localization again showed a similar pattern to Vasa depletion (Figure 4B). In the 
ovaries of vasa:AID:EGFP; nosGal4VP16>UASpTIR1 females, Vasa depletion started from 
oogenesis stage 9. In parallel, the TIR1 protein was expressed at a higher intensity in the later-
stage egg chambers (Figure 4C). To check the reversibility of the system, ovaries were 
analyzed two days after auxin removal, and we found that Vasa protein expression completely 
reappeared (Figure 4D). 
To confirm these results, the Vasa protein in ovaries of vasa:AID:EGFP; 
nosGal4VP16>UASpTIR1 females were further examined by Western blot analysis. After 
three days of auxin treatment, we found a dramatic decrease of Vasa protein levels in the 
ovaries. The small amount of residual protein is most likely due to the undegraded Vasa 
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expressed in the germarium and in early-stage egg chambers. Two days after auxin 
withdrawal, Vasa protein expression was fully restored (Figure 5). 
 
Vasa depletion by the AID system efficiently generates loss-of-function phenotypes 
As shown in Figure 4, Vasa depletion, detected in all of the investigated fly lines, did not 
influence the completion of oogenesis, and the ovaries were similar to the wild-type. This 
allowed us to examine the maternal effects of Vasa degradation on the laid embryos. 
Interestingly, the embryonic phenotypes were similar regardless of which Gal4 source was 
applied. In all cases, the vast majority of laid eggs failed to hatch. Cuticle preparations 
revealed that these embryos lack abdominal segments, showing a typical posterior phenotype 
caused by many hypomorphic vasa alleles (Figure 6) [1]. The anteroposterior and 
dorsoventral polarity of the oocytes developed normally, as we never observed eggs with a 
posterior micropyle or with fused or lacking dorsal appendages. Proper polarity was further 
confirmed by immunostaining of the Gurken protein in the ovary of auxin-treated 
vasa:AID:EGFP; mat-tub-Gal4>UASpTIR1 females. Gurken is the major determinant of 
oocyte polarity both along the anteroposterior and the dorsoventral axes [17,18]. We found 
that Gurken is expressed at the posterior pole of the egg chambers during early oogenesis, and 
it is subsequently localized to the dorsal-anterior corner of the oocyte, showing a typical wild-
type expression pattern (Figure 7). 
To explore the dynamics of auxin-induced protein degradation, embryos laid by the 
vasa:AID:EGFP; nosGal4VP16>UASpTIR1 females were further investigated over the 
course of time. Adult females were fed with 1M auxin for four days and their laid eggs were 
analyzed by cuticle preparations. Already on the first day, auxin treatment induced depletion 
of Vasa, as indicated by the appearance of embryos with abdominal defects. On the third day 
of auxin treatment, the posterior phenotype reached maximal penetrance, and only a few 
hatched larvae (1.94 %) were detected. The depletion was fully reversible, as indicated by the 
complete restoration of wild-type abdominal patterning after auxin withdrawal (Figure 8A). 
Consistently with the embryonic phenotypes, Western blot analysis revealed significant Vasa 
depletion in the laid eggs upon auxin treatment. Vasa protein reappeared one day after the 
auxin withdrawal and its level completely restored on the second day (Figure 8C). In the 
control experiment, we used vasa:AID:EGFP; UASpTIR1 flies without any Gal4 source to 
prevent TIR1 expression. In these flies, auxin treatment caused no substantial abdominal 
defect (Figure 8B). This result indicates that the observed posterior patterning defect is a 
direct consequence of the TIR1-mediated Vasa depletion and is not due to a side effect of the 
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auxin treatment. Furthermore, our results demonstrated that 1M auxin has no harmful 
maternal effects, as the percentage of undeveloped embryos did not change during the 
treatment (Figure 8A,B). 
 
The penetrance and expressivity of loss-of-function vasa phenotypes correlate with auxin 
concentration 
We next investigated whether the efficiency of protein depletion depend on the level of auxin. 
For this purpose, vasa:AID:EGFP; nosGal4VP16>UASpTIR1 flies were fed with increasing 
concentrations of auxin, and their progeny were analyzed. As shown in Figure 9A, the 
penetrance of the abdominal defects was directly proportional to the applied auxin 
concentration. Maximum penetrance was achieved by using 0.5-2 M auxin solution. Higher 
levels of auxin were less effective and possibly toxic, as the number of undeveloped embryos 
increased. Vasa degradation in the laid embryos was followed by Western blot which further 
supported that the efficiency of depletion correlates with the applied auxin concentration 
(Figure 9B). 
Vasa protein determines maternal phenotypes in a dose-dependent manner, as the moderate 
reduction in the amount of maternally provided Vasa results in sterility, whereas further 
reduction leads to abdominal defects. For example, females homozygous for the temperature 
sensitive vas
O14
 allele, at the restrictive temperature, produce viable progeny that show proper 
segmentation, but still lack germ cells [19]. Therefore, we checked the fertility of the viable 
progeny of females fed with lower concentrations of auxin (25-250 mM). The hatched larvae 
were allowed to develop until adulthood, and then their gonads were examined. We found that 
the majority (50-60%) of ovaries and testes were agametic showing a typical germ cell-less 
phenotype (Figure 10). These findings indicate that increasing the auxin concentration results 
in gradual protein depletion, which enables the generation of a phenotypic series. In this 
manner, we were able to find the threshold level of Vasa necessary for embryonic patterning 
but insufficient for germ cell formation. 
 
Auxin analogues are able to activate the AID system in Drosophila melanogaster 
It has been reported that synthetic auxin analogues 1-naphthaleneacetic acid (1-NAA) and 
2,4-dichlorophenoxyacetic acid (2.4-D) are able to activate the AID system in plants, 
however, they have a lower affinity to the TIR1 receptor [20,21]. Consistent with this result, 
we found that both analogues were able to induce Vasa depletion in vasa:AID:EGFP; 
nosGal4VP16>UASpTIR1 females, as indicated by the appearance of embryos with 
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abdominal defects (Figure 11). 1-NAA acted with a similar efficiency as auxin, whereas 
treatment with 2.4-D was less effective. This finding further demonstrates that the observed 
abdominal defect is not an aspecific effect of auxin since its synthetic analogues induce the 
same phenotype. Moreover, our result revealed that the minimal size AID motif used in this 
study retained the ability to activate the AID system by auxin analogues as well.  
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Discussion 
 
In the present study, we demonstrated that the plant-derived AID system can be efficiently 
employed in the female germline of Drosophila melanogaster. We showed that the small size 
of the AID motif enables highly efficient genomic integration by the CRISPR/Cas9-based 
technology. Insertion of the degron did not affect protein expression, localization, and the 
degron-tagged proteins were fully functional. Auxin can be easily administered by feeding, 
and in an optimal, effective concentration it has no adverse effects on the adult flies. Finally, 
adult flies expressing the TIR1 protein in their germline are viable and fertile. 
Our study involved two maternal genes to analyze the features of auxin-induced protein 
degradation in the ovary and in the early embryo. The vasa gene is expressed throughout  
oogenesis, and its protein is loaded directly into the egg, whereas the product of the nanos-
bcd3’UTR transgene is transferred into the oocyte as mRNA and translated only after 
fertilization [22,15]. The AID system was able to induce complete Vasa degradation at 
distinct stages of oogenesis, leading to a total lack of Vasa protein in the embryos. Depletion 
of the mislocalized Nanos demonstrated that the AID system is also active during the early 
embryonic stages. This result indicates that the TIR1 protein and auxin can be transported into 
the mature oocyte, allowing the AID system to induce protein degradation in the laid embryo. 
However, rescue of the bicaudal phenotype was only partial, as we could not detect normally 
segmented, viable larvae even after treatment with higher auxin concentrations (data not 
shown). This observation suggests that depletion of the mislocalized Nanos protein was 
incomplete. It may be due to the instability of the TIR1 protein or auxin, which results in 
lower concentrations in the laid embryo compared to the ovary, where the supply of these 
components is continuous. Staller MV et al. also found that maternally loaded shRNAs are 
less effective in the early embryo than they act directly in the ovary [5]. Another explanation 
of the partial rescue could be that the translation of the transgene is highly effective, and the 
action of mislocalized Nanos protein is faster than its degradation rate by the AID system. 
This hypothesis is supported by the fact that the anteriorly localized, ectopic Nanos possesses 
greater activity and induces abdomen formation in a lower concentration than localized 
posteriorly [15]. 
The dynamics of the AID system was similar for both proteins. The maternal effect of protein 
degradation appeared already after the first day of auxin treatment. This result indicates that 
the accumulation of auxin in the ovary takes less than one day. The egg chambers are 
permeable to auxin probably until the chorion wraps the mature oocyte. This occurs during 
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stages 13-14 and takes approximately three hours, which is only a short interval of the eight-
day-long adult oogenesis [23,24]. Presumably, auxin activates the AID system rapidly upon 
passing into the egg chambers, since in other model systems the target proteins were depleted 
as fast as 20-30 minutes, and a complete loss of the protein was observed within 1 hour in 
Drosophila S2R+ cells [11–14]. In adult flies, recovery occurred rapidly within one day after 
auxin withdrawal, indicating that the elimination of auxin from the ovary is also highly 
efficient. Consequently, these features allow rapid manipulation of protein levels by the AID 
system over a long period of oocyte development. 
Direct insertion of the AID motif into the genomic vasa locus enabled us to regulate the level 
of the endogenously expressed Vasa protein. Classical loss-of-function vasa alleles can affect 
the function and expression of other proteins since the alternative splice variant of vasa, the 
sisters-on-the-loose (solo) and the vasa intronic gene (vig), are also located in the same locus 
[25,26]. This complicates investigation of the specific role of the Vasa protein itself. 
Moreover, as Vasa is expressed throughout development, its adult phenotypes are influenced 
by earlier effects. Our AID-tagged vasa allele allowed us to examine specific vasa phenotypes 
during adult oogenesis.  
Various maternal Gal4 sources were tested for the expression of the TIR1 protein in the 
female germline. The pattern of Vasa depletion in the ovary correlated well with TIR1 
localization, demonstrating that the AID system is able to achieve a fine spatial control of 
protein destruction. The phenotypes obtained by the AID system were similar to those of 
hypomorphic vasa mutants: the flies did not exhibit any defects in oogenesis, and they laid 
numerous eggs. This result is not surprising, since none of the used Gal4 sources drove TIR1 
expression in all stages of oogenesis. However, Vasa depletion lead to maternal-effect 
lethality in all cases, since the laid embryos were not viable and failed to hatch. Embryonic 
lethality was caused exclusively by abdominal defects, as the dorsoventral axis of the 
embryos developed normally. All of these phenotypes highly resemble those observed in vas
1
 
mutants. In vas
1 
mutant females, the Vasa protein is expressed at the wild-type level in the 
germarium and in the early-stage egg chambers, but is absent later in oogenesis [19,22]. Our 
experiment using the mat-tub-Gal4 driver provides further evidence that Vasa expression in 
the germarium is sufficient for the completion of oogenesis, as well as for the establishment 
of dorsoventral polarity. Contrarily, in vasa-null ovaries, most of the egg chambers degenerate 
during the early vitellogenic stages, and the few laid eggs are strongly ventralized [27,28]. 
Therefore, it seems reasonable to speculate that the key events of oogenesis regulated by Vasa 
are restricted to the germarium. However, in the case of vasa-null alleles, we cannot exclude 
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that earlier developmental events interfere with the adult phenotypes. Furthermore, we found 
that the significant reduction in the level of Vasa in the germarium induced by the NGT-Gal4 
driver did not increase the severity of phenotypes even after ten days of auxin treatment. This 
result implies that only a small amount of Vasa protein is sufficient in the germarium for 
oocyte development. Consistently, even vas
LYG2
 homozygotes are able to complete oogenesis 
though the level of Vasa in their ovaries is only about 2% of the wild-type level [28]. 
Polarity defects observed in the vasa-null and strong hypomorphic vasa ovaries were 
explained by the greatly reduced level of the Gurken protein [28,29]. Furthermore, mutations 
in the vasa alleles that affect the DEAD-box RNA helicase domain or reduce binding to the 
translation initiation factor eIF5B prevent the accumulation of Gurken in the ovary [30,31]. 
These results imply that Vasa has a crucial role in the translation of gurken mRNA. Moreover, 
Tinker et al suggest that Vasa is also necessary for the proper localization of gurken mRNA 
[32]. Gurken is responsible for the establishment of the anteroposterior axis of the egg 
chamber during the early stages, and it subsequently specifies the dorsoventral axis of the 
oocyte during mid-oogenesis [17,18]. In contrast, we found that the anteroposterior polarity is 
maintained and the dorsoventral axis also develops properly even when Vasa is expressed 
only in the germarium. Consistently, the Gurken protein accumulated and localized as in the 
wild-type ovary. Our results are in agreement with a previous study suggesting that the 
translation of gurken is independent from Vasa during the later stages of oogenesis [29]. 
Alternatively, Vasa depletion was incomplete and a trace amount of Vasa remained in the 
vitellarium which was sufficient for Gurken translation. However we observed proper Gurken 
accumulation even after the Vasa level was further decreased by removing one copy of vasa 
(data not shown). 
The maternally loaded Vasa protein has an essential role in pole plasm assembly, which is 
responsible for germ cell specification as well as for somatic posterior patterning during early 
embryogenesis [1,22,19]. Accordingly, AID-induced Vasa depletion caused strong abdominal 
defects in the laid embryos. The severity of this phenotype was independent of whether Vasa 
was depleted only in the older egg chambers or it was already absent during the earlier stages 
as well because both cases resulted in a complete lack of abdomen. This indicates that Vasa 
expression in later-stage egg chambers is sufficient for the proper segmentation of the 
embryo. However, when the auxin concentration was reduced, the penetrance of embryos 
with abdominal defects decreased. Moreover, lower auxin concentrations resulted in less 
severe phenotypes ranging from the appearance of a few abdominal segments to normally 
developed and hatched embryos. Further investigations revealed that the vast majority of the 
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viable progeny were sterile, indicating that despite proper somatic segmentation, the 
development of germ cells was abolished in many cases. Consistently, it has been suggested 
previously that the threshold level of Vasa necessary for the determination of the posterior 
soma is less than that necessary to induce pole cell  formation [28]. Taken together, we 
conclude that the efficiency of Vasa degradation correlates with the applied auxin 
concentration. Consequently, auxin not only provides temporal control, but by altering its 
concentration, we can achieve distinct phenotypes and various degrees of penetrance.  
In summary, we have established a novel tool which enables precise analysis of adult and 
early embryonic phenotypes of maternal genes in Drosophila melanogaster. The AID system 
provides a fine spatiotemporal control of protein depletion and is able to generate different 
levels of protein knockdown in a well-regulated manner. All of these features make the AID 
system suitable for the investigation of pleiotropic proteins such as Vasa. The versatility of 
this method is enhanced by the rapidly developing genome editing and fosmid-based 
techniques that allow efficient insertion of the AID motif into any Drosophila protein [33,34] 
Moreover, a previous study demonstrated that this technique efficiently degrades proteins in 
somatic cells and works in larval stages as well, suggesting that the AID system can be a 
valuable tool in all fields of Drosophila genetics. 
  
14 
 
Materials and Methods 
 
Drosophila strains 
ΦC31X; attP 86Fa (#24486), ΦC31X; attP 58A (#24484), vas-Cas9 (#51324), w[1118]; 
Df(2L)BSC299/CyO (#23683); Oregon-R (#5); maternal Gal4 drivers: w
1118
; P{GAL4::VP16-
nos.UTR}CG6325
MVD1
 (nosGal4VP16) (#4937), w*; PenD14/CyO; P{GAL4-
nos.NGT}9/TM6B, Tb+ (NGT-Gal4) (#25394), w*; P{matα4-GAL-VP16}V37 (mat-tub-Gal4) 
(#7063) were obtained from the Bloomington Stock Center.  
 
Plasmid construction and transgenesis 
To generate the AID:nos-bcd3’UTR transgenic fly line, the pAttB-nos5'-AIDnosCDS-
bcd_nos3' plasmid was created via the following consecutive cloning steps. First, a Multi-
Cloning Site (MCS) was inserted between the HindIII (at position 4855) and SpeI (at position 
5986, after partial SpeI digestion due to another downstream SpeI site) sites of the pUAST-
AttB vector (Bischof et al. 2007, Genebank accession #: EF362409) on a synthetic double-
stranded oligonucleotide. By this insertion, the MCS replaced the UAS and SV40T sequences 
but left the AttB donor site in place. The separate components of the expression cassette were 
PCR-amplified from Drosophila genomic DNA template using the following primers; 
restriction sites are underlined: Nanos promoter: 5’-AAA GCT TCG ACC GTT TTA ACC 
TCG-3’ sense and 5’-GGA ATT CAA CAT GGC GAA AAT CCG GGT CG-3’ antisense 
primer. Nanos gene: 5’-AAG ATC TTC CGC AGC AAC TTG GAG GGC AG-3’ sense and 
5’-TAC GCG TCT AAA CCT TCA TCT GTT GCT TG-3’ antisense primer. Bicoid 3’UTR 
(does not contain the nos response element): 5’-TAC GCG TAG AAA GTT AGG TCT AGT 
C-3’ sense and 5’-ACT CGA GGC CTA ACA GAT TGC AAT GCT C-3’ antisense primer. 
Nanos polyA: 5’-GCT CGA GTG CCA AAT AAA GAA ATG G-3’ sense and 5’-CTC TAG 
AGA ACG CTT TCC GGA CGT AGA G-3’ antisense primer. The auxin-inducible degron 
(AID) sequence was PCR-amplified from the pSM409 plasmid (gift from Helle D. Ulrich) 
containing the 44-amino acid minimal degron derived from the Arabidopsis thaliana IAA17 
protein [12]. For amplification, the following oligos were used: 5’-TGA ATT CCA TGC CTA 
AAG ATC CAG CCA AAC CTC-3’ sense and 5’-AAG ATC TTC ACG AAC GCC GCC 
GCC TCC-3’ antisense primers. The PCR products were digested with restriction enzymes 
and subcloned into the TopoTA PCR cloning vector (Thermo Fisher Scientific). The 
components were then transferred one by one from the TopoTA subclones into the MCS in 
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the following order: nos5’ by HindIII-EcoRI double digestion, AID sequence with EcoRI-
BglII, bcd 3’UTR with MluI-XhoI, nos polyA by XhoI-XbaI and finally, the nos genomic 
gene by BglII-MluI. The pAttB-nos5
’
-AIDnosCDS-bcd-nos3’ plasmid was integrated at the 
attP58A3 landing site. 
For the TIR1 expression construct, the OsTIR1-9xMyc sequence was PCR-amplified from the 
pNHK53 plasmid (NBRP-Yeast, BYP6744) using 5’-AAA GGT ACC GCC ACC ATG ACG 
TAC TTC CCG GAG GA-3’ sense (where the KpnI site is underlined) and 5’-AAA GGA 
TCC TTA GCT AGT GGA TCC GTT CAA GTC-3’ antisense (where the BamHI site is 
underlined) primers. The PCR product was digested with KpnI and BamHI restriction 
enzymes and cloned into the pUASp-K10attB vector. The pUASp-K10attB vector enabling 
germline-specific gene expression was a kind gift from Beat Suter [35]. The construct was 
integrated into the genome at the attP58A3 and attP86E18 landing sites. 
 
Tagging via the CRISPR/Cas9-based technology 
To search for guide RNA target sites near the C-terminal end of the vasa gene, the flyCRISPR 
Optimal Target Finder website (http://tools.flycrispr.molbio.wisc.edu/targetFinder) was used. 
Two guide RNA recognition sites, located in the last intron: 5’-
GCGTGGCAGGGTGAGTAAACTGG-3’ and downstream of the vasa 3’UTR in intergenic 
region: 5’-CCCAACTAATACCGTGTACTATC-3’ (the PAM sequences are underlined), 
were selected.  The target site sequences were cloned into the pU6-BbsI-chiRNA plasmid 
(Addgene, #45946) [36] with the following oligos: 5’-CTT CGC GTG GCA GGG TGA GTA 
AAC-3’ sense and 5’-AAA CGT TTA CTC ACC CTG CCA CGC-3’ antisense oligos for 
cloning the intronic target site; 5’-CTT CGA TAG TAC ACG GTA TTA GTT-3’ sense and 
5’-AAA CAA CTA ATA CCG TGT ACT ATC-3’ antisense oligos for cloning the intergenic 
target site. The cleavage efficiency of guide RNAs was tested in the vas>Cas9 line by 
embryonic PCR according to the protocol on the 
http://flycrispr.molbio.wisc.edu/protocols/embryonicPCR website. The expected 425 bp 
deletion produced by the guide RNA pair was clearly demonstrated by gel electrophoresis. 
For construction of the repair template, homology sequences were PCR-amplified from 
genomic DNA of the w
1118
 fly strain. PCR products were cloned into the pSM409 C-terminal 
tagging plasmid (gift from Helle D. Ulrich) harbouring the minimal truncated form of the AID 
sequence fused to EGFP tag [12]. The 1550 bp genomic fragment right before the stop codon 
was cloned using the 5’-AAA ACA GCT GAC AAC ATA CCG GTT AAG GTA ACA A-3’ 
sense (PvuII site is underlined) and 5’- AAA GTC GAC ATC CCA TTG CTC TTC TTC CT-
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3’ antisense (SalI site is underlined) primers. After digestion with PvuII and SalI, the PCR 
product was cloned into the pSM409 plasmid upstream of the AID-EGFP tag. The 1730 bp 
genomic fragment right after the stop codon was PCR-amplified with the  5’- AAA GGC 
GCG CCA ATG TAT GGA CAT AGA TTT C-3’ sense (AscI site is underlined) and 5’- 
AAA GAG CTC AAT TTG GCA CTC ACC ATT CT-3’ antisense (SacI site is underlined) 
primers. The PCR product was digested with AscI and SacI enzymes and cloned into the 
pSM409 plasmid downstream of the AID-EGFP tag. 
To prevent cutting of the repair template, guide RNA recognition sites were eliminated on the 
plasmid using a site-directed mutagenesis kit (Agilent Technologies, #210518). The following 
mutagenic primers were applied to mutate the intronic target site (mutated nucleotides are 
emboldened): 5'-GTG CGT GGC AGG GTG AGT AAA GTC CAA AAA CTT CTT TTG 
TTT TGC AC-3' sense and  5'-GTG CAA AAC AAA AGA AGT TTT TGG ACT TTA CTC 
ACC CTG CCA CGC AC-3' antisense primers. The intergenic target site was mutated to 
create NheI and XhoI restriction sites to aid further cloning of the DsRed marker gene. The 
following mutagenic primers were used (mutated nucleotides are emboldened; NheI site is 
double underlined; XhoI site is underlined): 5'-GTT GCA AAA CTT AAC AGA  AAC GTG 
CAC TTT GAT GCT AGC TAA TCT CGA GTA CTA TCA TGT GTT TGG TTT TAA 
GTA CTC ATC-3' sense and 5'-GAT GAG TAC TTA AAA CCA AAC ACA TGA TAG 
TAC TCG AGA TTA GCT AGC ATC AAA GTG CAC GTT TCT GTT AAG TTT TGC 
AAC-3' antisense primers. 
3xP3 DsRed cassettes flanked by loxP sites were excised from the pHD-DsRed plasmid 
(Addgene #51434) [37] with XhoI and NheI digestion and subcloned into the repair template 
plasmid. 
The pU6-BbsI-chiRNA plasmids (250-250 ng/µl) and the repair template plasmid (500 ng/µl) 
were mixed and injected into embryos of the vas>Cas9 fly line. The progeny of injected flies 
were screened for eye-specific expression of the DsRed marker gene. Proper integration of the 
repair template was confirmed by sequencing. 
 
Cuticle preparation 
Embryos were collected 24 hours after egg laying and dechorionated by rinsing with 50% 
bleach. Dechorionated embryos were then mounted in 1:1 mixture of Hoyer’s medium and 
lactic acid and incubated at 60°C overnight. 
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Western blot 
For western blot analysis, ovaries were dissected from 4- and 6-day-old females. 0-2-hour-old 
embryos were dechorionated by rinsing with 50% bleach. Samples were homogenized by 
sonication in Laemmli buffer (50 mM Tris-HCl pH6.8, 2% SDS, 0.1 % bromphenol blue, 
10% glycerol, 100 mM 2-mercaptoethanol, supplemented with complete protease inhibitor 
cocktail (Roche, #10481900) and heat denatured (100°C, 5 min). Proteins were 
electrophoresed on 10% SDS-polyacrylamide gel and subsequently transferred onto PVDF 
membrane (Millipore) for immunoblotting. Membranes were incubated in rabbit anti-GFP 
(1:6000, Life Technologies) or mouse anti-β-tubulin (1:300, DSHB) primary antibodies at 4 
°C overnight. Secondary antibodies were HRP-conjugated anti-rabbit IgG (1:10000, Sigma) 
or HRP-conjugated anti-mouse IgG (1:6000, Sigma) antibodies. Immunocomplexes were 
visualized by enhanced chemiluminescence reaction (Millipore). 
 
Immunostaining  
Ovaries were dissected from 4-day-old females and fixed in PBS with 4% formaldehyde for 
20 min. Early embryos (0-60 min) were dechorionated in 50% bleach and fixed for 30 min in 
1:1 mixture of heptane and 4% formaldehyde. Subsequently, embryos were devitellinized in 
1:1 mixture of methanol/heptan solution by vigorous shaking. The samples were incubated 
with mouse anti-c-myc (1:100, Santa Cruz Biotechnology), mouse anti-Gurken (1:10, 1D12, 
DSHB) or goat anti-Vasa (1:100, Santa Cruz Biotechnology) primary antibody at 4 °C 
overnight. Anti-mouse Alexa Fluor 546 (1:600, Life Technologies) and anti-goat Alexa Fluor 
546 (1:600, Life Technologies) were used as secondary antibody, and DAPI (200 ng/ml, 
Sigma) was also applied. Stained ovaries and embryos were mounted in Fluoromount-G 
medium (SouthernBiotech, #0100-01). All micrographs were taken using a Leica SP5 
confocal laser scanning microscope. 
 
Treatment with auxin and auxin analogues 
Ten female and five male flies were placed in egg laying vials containing apple juice agar. 
100 µl auxin (Sigma, I5148), 1-naphthylacetic acid (1-NAA) (Sigma, #N0640), or 2,4-
dichlorophenoxyacetic acid 2,4 (2,4-D) (Sigma, #D7299) dissolved in water (0.025-4M) were 
mixed with 500 mg inactive yeast extract (Molar Chemicals). The yeast paste was spotted 
onto the wall of the vial. Flies were transferred into new vials with fresh yeast paste every day 
and kept at 25 °C in the dark. 
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Figure legends 
 
Figure 1. Degradation of the AID-tagged Nanos protein by the AID system. (A-C) 
Cuticle preparations from 24-hour-old embryos. Embryos are shown with anterior to the left. 
(A) A wild-type embryo, possessing a head, three thoracic, and eight abdominal segments. (B) 
A bicaudal embryo produced by a female expressing a mislocalized form of the Nanos protein 
(AID:nos-bcd3’UTR). Such embryos lack head structures and thoracic segments and form two 
abdomens consisting of 3-5 abdominal segments. As a result of this duplication, posterior 
terminal structures, such us the filzkörper (arrow), are located at both poles of the embryo. 
(C) Embryos laid by AID:nos-bcd3’UTR; nosGal4VP16>UASpTIR1 females after auxin 
administration.  Embryos show a suppressed bicaudal phenotype as they have an elongated 
shape with 6-8 abdominal segments and the filzkörper (arrow) has disappeared from the 
anterior side. (D) Time course of the auxin treatment. Females expressing the AID-tagged 
mislocalized form of Nanos and the TIR1 protein were crossed with w
1118
 males. Flies were 
fed with 1M auxin solution/yeast extract mixture. Auxin was withdrawn after one week, and 
flies were kept for an additional two days. Eggs were collected (N>100) daily, and the 
penetrance of cuticular phenotypes was determined. 
 
Figure 2. Strategy for tagging the vasa gene by CRISPR/Cas9-induced homologous 
recombination. Guide RNA target sites (arrows) located in the last intron and downstream of 
the 3’UTR of the vasa gene. The donor construct was designed to insert the AID:EGFP tag 
right before the stop codon. The DsRed marker gene with the eye-specific 3XP3 promoter 
was introduced after the vasa locus into the intergenic region. LoxP sites allow the excision of 
the 3XP3 DsRed cassette by the Cre/loxP system. Introns and intergenic regions are shown as 
a line.  
 
Figure 3. Expression pattern of the AID:EGFP-tagged (A-A’) and wild-type (B) Vasa 
protein. (A) Vasa protein (green) in vasa:AID:EGFP homozygous flies was detected by 
EGFP fluorescence. (A’,B) Vasa protein (red) in vasa:AID:EGFP homozygous flies (A’) and 
in Oregon strain (B) was detected by staining with vasa antibody. DAPI labels the nuclei 
(blue). Adult ovarioles, adult germaria and early embryos are shown with anterior to the left. 
In ovarioles, Vasa protein accumulates around the nuclei of nurse cells and at the posterior 
pole of the developing oocyte. Scale bar represents 100µm. In germaria, Vasa protein is 
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expressed around the nuclei of germ cells. Scale bar represents 10µm. In early embryos, Vasa 
protein accumulates at the posterior pole. Scale bar represents 100µm. 
 
Figure 4. Expression of AID:EGFP-tagged Vasa and the TIR1 protein in auxin-treated 
ovaries. UASpTIR1:9xMyc was expressed by mat-tub-Gal4 (A) NGT-Gal4 (B) and 
nosGal4VP16 (C-D) drivers in the ovary of homozygous vasa:AID:EGFP flies. Ovarioles are 
shown with anterior to the left. The tagged Vasa protein is green. The Myc-tagged TIR1 
protein (red) was stained with anti-Myc antibody. DAPI labels the nuclei (blue). Scale bar 
represents 100µm. (A-C) Flies were fed with 1M auxin solution/yeast extract mixture for 
three days, and then their ovaries were stained. Inset in B shows magnified view of the 
germarium. Scale bar represents 20µm. (D) Flies were fed with 1M auxin solution/yeast 
extract mixture for three days, and their ovaries were stained after two days of auxin 
withdawal.  
 
Figure 5. Western blot analysis of the Vasa:AID:EGFP protein in the ovary of 
vasa:AID:EGFP, nosGal4VP16>UASpTIR1 females. Flies were fed with 1M auxin 
solution/yeast extract mixture for three days. After the treatment, auxin was withdrawn and 
flies were kept for additional two days. Control flies of the same age and without auxin 
treatment were also examined. The Vasa:AID:EGFP protein was labeled with anti-GFP 
antibody; β-tubulin served as a loading control. 
 
Figure 6. Cuticular phenotype of a first instar larva produced by vasa:AID:EGFP, 
nosGal4VP16>UASpTIR1 females before (A) and after (B) auxin treatment. Samples 
were collected after 24 hours of egg laying. Larvae are shown with anterior to the left. A. 
Larva shows wild-type phenotype with head, three thoracic, and eight abdominal segments. B. 
Larva lacks abdominal segments, showing the classical posterior vasa phenotype. 
 
Figure 7. Expression of the Gurken protein in the ovary of the vasa:AID:EGFP; mat-tub-
Gal4>UASpTIR1 females. Ovarioles are shown with anterior to the left. Flies were fed with 
yeast extract (A) or with 1M auxin solution/yeast extract mixture (B) for three days, and then 
their ovaries were stained. The tagged Vasa protein is green. The Gurken protein (red) was 
stained with anti-Gurken antibody. DAPI labels the nuclei (blue). Scale bar represents 100 
µm. Gurken is located at the posterior pole of the oocyte (arrows) in the early stage egg 
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chambers. During the mid-oogenesis Gurken is found at the dorsal-anterior corner of the 
oocyte (arrowhead).  
 
Figure 8. Reversible depletion of the AID:EGFP-tagged Vasa protein by the AID system. 
vasa:AID:EGFP, nosGal4VP16>UASpTIR1 females (A) and vasa:AID:EGFP, UASpTIR1 
females (B) were crossed with w
1118
 males and fed with 1M auxin solution/yeast extract 
mixture for four days. After the treatment, auxin was withdrawn, and the flies were kept for 
an additional two days. Eggs were collected (N>100) daily, and the penetrance of cuticular 
phenotypes was determined. (C) Western blot analysis of the Vasa protein in laid eggs of 
auxin treated vasa:AID:EGFP, nosGal4VP16>UASpTIR1 females. 0-2-hour old eggs were 
collected daily. The Vasa:AID:EGFP protein was labeled with anti-GFP antibody; β-tubulin 
served as a loading control. 
 
Figure 9. Auxin induces protein degradation in a concentration-dependent manner. 
vasa:AID:EGFP, nosGal4VP16>UASpTIR1 females were crossed with w
1118
 males. Flies 
were fed with auxin solution/yeast extract mixture, prepared in increasing concentrations (0-
4M) of auxin. (A) Eggs were collected (N>100) after three days, and the penetrance of 
cuticular phenotypes was determined. (B) Western blot analysis of the Vasa protein in laid 
eggs. 0-2-hour old eggs were collected daily. The Vasa:AID:EGFP protein was labeled with 
anti-GFP antibody; β-tubulin served as a loading control. 
 
Figure 10. Partial Vasa degradation by low auxin concentrations results in a 
grandchildless phenotype. vasa:AID:EGFP, nosGal4VP16>UASpTIR1 females were 
crossed with w
1118
 males and fed with auxin (0-250 mM)/yeast extract mixture for three days. 
Gonads were dissected from female (A) and male (B) adult progeny (N>50) of the auxin-
treated flies. Penetrance of flies with normal gonads and flies where one (mosaic) or both 
gonads showed agametic phenotype was determined. 
 
Figure 11. Auxin analogues are able to activate the AID system. vasa:AID:EGFP, 
nosGal4VP16>UASpTIR1 females were crossed with w
1118
 males and fed with yeast paste 
prepared with 25 mM and 200 mM 2,4-dichlorophenoxyacetic acid (2,4-D) and 1-
naphthaleneacetic acid (1-NAA). After three days, the laid eggs were collected (N>100), and 
the penetrance of cuticular phenotypes was determined. 
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